KRAS Wild-Type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential.
Clinical cancer research : an official journal of the American Association for Cancer Research
| Authors | |
| Abstract | In a landscape dominated by pivotal KRAS mutations, there has been limited exploration of KRAS wild-type pancreatic cancer. A recent study highlights other mitogen-activated kinase pathway alterations as alternative drivers in these tumors, which holds the key to unlocking a realm of targeted therapies for patients with this understudied cancer subtype. See related article by Singh et al., p. 4627. |
| Year of Publication | 2023
|
| Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
|
| Volume | 29
|
| Issue | 22
|
| Pages | 4527-4529
|
| Date Published | 11/2023
|
| ISSN | 1557-3265
|
| DOI | 10.1158/1078-0432.CCR-23-2221
|
| PubMed ID | 37695631
|
| Links |